Clinical Trials in Kufstein, Austria
3 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Metastatic Breast Cancer in Austria
Breast CancerBreast CarcinomaBreast Tumor
Arbeitsgemeinschaft medikamentoese Tumortherapie5,000 enrolled16 locationsNCT03870620
Recruiting
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
Chronic Lymphocytic Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie500 enrolled9 locationsNCT06250465
Recruiting
Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Multiple Myeloma (MM)Chronic Lymphocytic Leukaemia (CLL)Secondary Immunodeficiency (SID)
Medical University Innsbruck120 enrolled5 locationsNCT06821880